Cart
sales@molnova.com
Cefprozil hydrate
CAS No. 121123-17-9
Cefprozil hydrate( Cefprozil hydrate )
Catalog No. M10789 CAS No. 121123-17-9
Cefprozil hydrate (Cefzil) is a second-generation cephalosporin type antibiotic.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 10MG | 35 | In Stock |
|
| 25MG | 48 | In Stock |
|
| 50MG | 65 | In Stock |
|
| 100MG | 96 | In Stock |
|
| 200MG | 138 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCefprozil hydrate
-
NoteResearch use only, not for human use.
-
Brief DescriptionCefprozil hydrate (Cefzil) is a second-generation cephalosporin type antibiotic.
-
DescriptionCefprozil hydrate (Cefzil) is a second-generation cephalosporin type antibiotic.
-
In Vitro——
-
In Vivo——
-
SynonymsCefprozil hydrate
-
PathwayGPCR/G Protein
-
TargetAntibacterial
-
RecptorPBPs
-
Research AreaInfection
-
Indication——
Chemical Information
-
CAS Number121123-17-9
-
Formula Weight407.44
-
Molecular FormulaC18H21N3O6S
-
Purity>98% (HPLC)
-
SolubilitySoluble in water
-
SMILESO=C(C(N12)=C(/C=C/C)CS[C@]2([H])[C@H](NC([C@H](N)C3=CC=C(O)C=C3)=O)C1=O)O.[H]O[H]
-
Chemical Name(6R,7R)-7-[[(2R)-2-Amino-2-(4-hydroxyphenyl)acetyl]amino]-8-oxo-3-[(E)-prop-1-enyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid hydrate
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Nagai K, et al . Antimicrob Agents Chemother. 2002 May;46(5):1273-80.
molnova catalog
related products
-
Tildipirosin
Tildipirosin is a 16-membered macrolide used as an antibiotic in veterinary medicine. Like other macrolides it inhibits protein synthesis in bacteria and blocks the production of biofilms.
-
Diniconazole
Diniconazole is a fungicide. It is known as a plant hormone abscisic acid (ABA) catabolic inhibitor and acts as a potent competitive inhibitor of recombinant Arabidopsis ABA 8'-hydroxylase CYP707A3.
-
Tigemonam
Tigemonam is a monobactam, a novel orally administered monobactam that protects against gram-negative aerobic bacterial pathogens and is at least as active against clinical isolates of Enterobacteriaceae as amitraz or carmonan (MIC90: 0.06-16 mg/l).
